{
    "Trade/Device Name(s)": [
        "ADVIA Centaur\u00ae Progesterone (PRGE) Master Curve Material",
        "ADVIA Centaur\u00ae Ferritin (FER) Master Curve Material"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "k143376",
    "Predicate Device Reference 510(k) Number(s)": [
        "k103683",
        "k102267"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "November 24, 2014",
    "Summary Letter Received Date": "November 25, 2014",
    "Submission Date": "December 23, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Progesterone",
        "Ferritin"
    ],
    "Specimen Type(s)": [
        "Human plasma",
        "Human serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur\u00ae Systems",
        "ADVIA Centaur XP system"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur Progesterone and Ferritin Master Curve Materials as calibration verification controls for ADVIA Centaur immunoassays",
    "Indications for Use Summary": "For in vitro diagnostic use in the verification of calibration and reportable range of the ADVIA Centaur Progesterone and Ferritin assays",
    "fda_folder": "Clinical Chemistry"
}